Birendra S Kumar, MD - Medicare Hematology/oncology in Mankato, MN

Birendra S Kumar, MD is a medicare enrolled "Internal Medicine - Hematology & Oncology" physician in Mankato, Minnesota. He graduated from medical school in 1991 and has 33 years of diverse experience with area of expertise as Hematology/oncology. He is a member of the group practice Fairview Express Care and his current practice location is 1230 E Main St, Mankato Clinic At Main Street, Mankato, Minnesota. You can reach out to his office (for appointments etc.) via phone at (507) 625-1811.

Birendra S Kumar is licensed to practice in Minnesota (license number 39113) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1063491066.

Contact Information

Birendra S Kumar, MD
1230 E Main St, Mankato Clinic At Main Street,
Mankato, MN 56001-5066
(507) 625-1811
Not Available



Physician's Profile

Full NameBirendra S Kumar
GenderMale
SpecialityHematology/oncology
Experience33 Years
Location1230 E Main St, Mankato, Minnesota
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Birendra S Kumar graduated from medical school in 1991
  NPI Data:
  • NPI Number: 1063491066
  • Provider Enumeration Date: 01/10/2006
  • Last Update Date: 09/09/2016
  Medicare PECOS Information:
  • PECOS PAC ID: 3375516123
  • Enrollment ID: I20040819001432

Medical Identifiers

Medical identifiers for Birendra S Kumar such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1063491066NPI-NPPES
335L2KUOtherMNBCBS
P00211303OtherRR MEDICARE
256514500MedicaidMN
3600541OtherMNMEDICA
NA2951011969OtherMNPREFERRED ONE
0593046MedicaidIA
115710OtherMNUCARE
773738OtherMNAMERICAS PPO
HP21623OtherMNHEALTH PARTNERS
41084933956001C219OtherCHAMPUS

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207R00000XInternal Medicine 39113 (Minnesota)Secondary
207RH0003XInternal Medicine - Hematology & Oncology 39113 (Minnesota)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Fairview Southdale HospitalEdina, MNHospital
University Of Minnesota Medical Center, FairviewMinneapolis, MNHospital
Fairview Ridges HospitalBurnsville, MNHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Fairview Express Care33756451791523

News Archive

Natural compound in snake venom for treatment of malignant tumours

Researchers at the University of South Australia have made a major discovery using a natural compound in snake venom that shows very promising anti-cancer effects. The compound works by activating the destruction of cells which make up the blood vessels that supply nutrients to tumours, according to Associate Professor Tony Woods from UniSA's School of Pharmaceutical, Molecular and Biomedical Sciences.

UCLA/Pitt scientists uncover P. acnes virus with potential to kill zits

Watch out, acne. Doctors soon may have a new weapon against zits: a harmless virus living on our skin that naturally seeks out and kills the bacteria that cause pimples.

NIH honors Utah biochemist with Pioneer Award for dsRNA research

University of Utah biochemist Brenda L. Bass, Ph.D., has dedicated her career to following the path less traveled.

Cardiff University technique could help predict IVF embryos with best success chances

A new technique successfully used in mice to identify embryos likely to result in a successful pregnancy could be used in humans, potentially boosting IVF success rates and helping to reduce the number of multiple births, according to Cardiff University scientists.

Ohm receives U.S. FDA approval to manufacture and market Valsartan

Ohm Laboratories, Inc., a wholly owned subsidiary of Ranbaxy Laboratories Limited, announced today that Ohm has received approval from the U.S. Food and Drug Administration to manufacture and market Valsartan 40 mg, 80 mg, 160 mg, and 320 mg tablets on an exclusive basis.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Birendra S Kumar allows following entities to bill medicare on his behalf.
Entity NameFairview Health Services
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1013994359
PECOS PAC ID: 1951213057
Enrollment ID: O20031105000461

News Archive

Natural compound in snake venom for treatment of malignant tumours

Researchers at the University of South Australia have made a major discovery using a natural compound in snake venom that shows very promising anti-cancer effects. The compound works by activating the destruction of cells which make up the blood vessels that supply nutrients to tumours, according to Associate Professor Tony Woods from UniSA's School of Pharmaceutical, Molecular and Biomedical Sciences.

UCLA/Pitt scientists uncover P. acnes virus with potential to kill zits

Watch out, acne. Doctors soon may have a new weapon against zits: a harmless virus living on our skin that naturally seeks out and kills the bacteria that cause pimples.

NIH honors Utah biochemist with Pioneer Award for dsRNA research

University of Utah biochemist Brenda L. Bass, Ph.D., has dedicated her career to following the path less traveled.

Cardiff University technique could help predict IVF embryos with best success chances

A new technique successfully used in mice to identify embryos likely to result in a successful pregnancy could be used in humans, potentially boosting IVF success rates and helping to reduce the number of multiple births, according to Cardiff University scientists.

Ohm receives U.S. FDA approval to manufacture and market Valsartan

Ohm Laboratories, Inc., a wholly owned subsidiary of Ranbaxy Laboratories Limited, announced today that Ohm has received approval from the U.S. Food and Drug Administration to manufacture and market Valsartan 40 mg, 80 mg, 160 mg, and 320 mg tablets on an exclusive basis.

Read more Medical News

› Verified 7 days ago

Entity NameFairview Express Care
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1053952606
PECOS PAC ID: 3375645179
Enrollment ID: O20081028000548

News Archive

Natural compound in snake venom for treatment of malignant tumours

Researchers at the University of South Australia have made a major discovery using a natural compound in snake venom that shows very promising anti-cancer effects. The compound works by activating the destruction of cells which make up the blood vessels that supply nutrients to tumours, according to Associate Professor Tony Woods from UniSA's School of Pharmaceutical, Molecular and Biomedical Sciences.

UCLA/Pitt scientists uncover P. acnes virus with potential to kill zits

Watch out, acne. Doctors soon may have a new weapon against zits: a harmless virus living on our skin that naturally seeks out and kills the bacteria that cause pimples.

NIH honors Utah biochemist with Pioneer Award for dsRNA research

University of Utah biochemist Brenda L. Bass, Ph.D., has dedicated her career to following the path less traveled.

Cardiff University technique could help predict IVF embryos with best success chances

A new technique successfully used in mice to identify embryos likely to result in a successful pregnancy could be used in humans, potentially boosting IVF success rates and helping to reduce the number of multiple births, according to Cardiff University scientists.

Ohm receives U.S. FDA approval to manufacture and market Valsartan

Ohm Laboratories, Inc., a wholly owned subsidiary of Ranbaxy Laboratories Limited, announced today that Ohm has received approval from the U.S. Food and Drug Administration to manufacture and market Valsartan 40 mg, 80 mg, 160 mg, and 320 mg tablets on an exclusive basis.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Birendra S Kumar is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Birendra S Kumar, MD
110105 Pioneer W Trl 302,
Chaska, MN 55318-2680

Ph: (952) 361-5800
Birendra S Kumar, MD
1230 E Main St, Mankato Clinic At Main Street,
Mankato, MN 56001-5066

Ph: (507) 625-1811

News Archive

Natural compound in snake venom for treatment of malignant tumours

Researchers at the University of South Australia have made a major discovery using a natural compound in snake venom that shows very promising anti-cancer effects. The compound works by activating the destruction of cells which make up the blood vessels that supply nutrients to tumours, according to Associate Professor Tony Woods from UniSA's School of Pharmaceutical, Molecular and Biomedical Sciences.

UCLA/Pitt scientists uncover P. acnes virus with potential to kill zits

Watch out, acne. Doctors soon may have a new weapon against zits: a harmless virus living on our skin that naturally seeks out and kills the bacteria that cause pimples.

NIH honors Utah biochemist with Pioneer Award for dsRNA research

University of Utah biochemist Brenda L. Bass, Ph.D., has dedicated her career to following the path less traveled.

Cardiff University technique could help predict IVF embryos with best success chances

A new technique successfully used in mice to identify embryos likely to result in a successful pregnancy could be used in humans, potentially boosting IVF success rates and helping to reduce the number of multiple births, according to Cardiff University scientists.

Ohm receives U.S. FDA approval to manufacture and market Valsartan

Ohm Laboratories, Inc., a wholly owned subsidiary of Ranbaxy Laboratories Limited, announced today that Ohm has received approval from the U.S. Food and Drug Administration to manufacture and market Valsartan 40 mg, 80 mg, 160 mg, and 320 mg tablets on an exclusive basis.

Read more News

› Verified 7 days ago


Internal Medicine Doctors in Mankato, MN

Ripudamanjit Singh, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 1025 Marsh St, Mankato, MN 56001
Phone: 507-625-4031    
Stephan Thome, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 1025 Marsh St, Mankato, MN 56001
Phone: 507-625-4031    
Suresh Devineni, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 1230 E Main St, Mankato, MN 56001
Phone: 507-625-1811    
Diana Franco Corso, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 1025 Marsh St, Mankato, MN 56001
Phone: 507-625-4031    
Manpreet Kanwar, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 1230 E Main St, Mankato Clinic, Mankato, MN 56002
Phone: 507-625-1811    
Kingsley Iheasirim, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 1025 Marsh St, Mankato, MN 56001
Phone: 507-625-4031    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.